Essential Phosphates, UAB - financials and debts

Company age: 8 y. 5 mo.

Update

Essential Phosphates - Company finances

EUR
2018
From: 2018-04-23
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 11,000 - 540,892 99,032 113,660 1,441,307 920,470 1,676,022
Profit before tax 4,272 -454,917 -1,050,605 -835,986 -619,995 -295,593 167,311 332,568
Net profit 4,272 -454,917 -1,050,605 -835,986 - -231,218 161,952 269,996
Equity 6,772 -148,145 -498,750 -1,334,738 -894,096 52,577 214,529 484,525
Liabilities 2,985 2,231,150 2,139,361 2,373,888 2,846,535 1,552,388 1,438,911 1,608,416
Non-current assets 0 645,554 1,594,003 961,587 1,831,148 1,324,660 1,315,438 856,187
Current assets 7,803 405,847 171,308 77,500 121,291 280,305 338,002 1,236,754
Total assets 7,803 1,051,401 1,765,311 1,039,087 1,952,439 1,604,965 1,653,440 2,092,941
Taxes paid
STI taxes - - - - - 101,896 197,096 227,566
Social insurance contributions - - - - - 61,213 80,580 78,771
Financial indicators
Revenue change y/y - - - -81.7% +14.8% +1168.1% -36.1% +82.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 54.7% -43.3% -59.5% -80.5% - -14.4% 9.8% 12.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 63.1% - - - - -439.8% 75.5% 55.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 38.8% - -194.2% -844.2% - -16.0% 17.6% 16.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 38.8% - -194.2% -844.2% -545.5% -20.5% 18.2% 19.8%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.4 - - - - 29.5 6.7 3.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 7,333 - 23,432 7,291 10,492 144,131 64,974 87,066

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Essential Phosphates - Social security debts

From To Debt, €
2025-06-26 2025-07-13 1149.46
2025-06-17 2025-06-25 1149.48
2025-06-11 2025-06-11 2280.48
2025-06-08 2025-06-09 2280.48
2025-05-16 2025-06-04 2280.48
2025-05-04 2025-05-13 3411.48
2025-04-16 2025-04-30 3411.48
2025-03-21 2025-04-13 4542.48
2025-03-20 2025-03-20 4458.07
2025-03-18 2025-03-19 4542.48
2025-02-18 2025-03-13 5673.48
2025-02-16 2025-02-16 6804.48
2025-02-11 2025-02-15 6804.48
2025-01-16 2025-02-10 6905.19
2025-01-02 2025-01-14 7935.46
2024-12-22 2024-12-31 7935.46
2024-12-17 2024-12-20 7935.46
2024-12-16 2024-12-16 998.04
2024-11-19 2024-12-15 9066.46
2024-11-18 2024-11-18 18509.92
2024-11-15 2024-11-17 9066.46
2024-10-16 2024-11-14 10197.46
2024-10-14 2024-10-15 2558.64
2024-09-17 2024-10-13 11328.46
2024-09-16 2024-09-16 4689.57
2024-08-19 2024-09-15 12459.46
2024-08-12 2024-08-18 5823.34
2024-07-16 2024-08-11 13590.46
2024-07-15 2024-07-15 6928.60
2024-07-11 2024-07-14 13590.46
2024-06-18 2024-07-10 14721.46
2024-06-14 2024-06-17 7544.76
2024-05-16 2024-06-13 15852.46
2024-05-15 2024-05-15 11011.39
2024-04-23 2024-05-14 16983.66
2024-04-16 2024-04-22 16983.46
2024-04-15 2024-04-15 12241.41
2024-03-18 2024-04-14 18114.46
2024-03-15 2024-03-17 13564.23
2024-02-19 2024-03-14 19268.16
2024-02-14 2024-02-18 12666.78
2024-01-31 2024-02-13 17830.01
2024-01-23 2024-01-30 17830.01
2024-01-16 2024-01-22 17829.95
2024-01-15 2024-01-15 11041.38
2023-12-18 2024-01-11 21507.46
2023-12-14 2023-12-17 16782.03
2023-12-06 2023-12-13 22638.46
2023-12-05 2023-12-05 22641.51
2023-11-21 2023-12-04 22638.46
2023-11-20 2023-11-20 22595.24
2023-11-16 2023-11-19 22638.46
2023-11-15 2023-11-15 17788.36
2023-10-17 2023-11-14 23769.46
2023-10-16 2023-10-16 18786.27
2023-09-26 2023-10-15 24873.53
2023-09-25 2023-09-25 24406.66
2023-09-18 2023-09-24 24873.53
2023-09-14 2023-09-17 20133.64
2023-09-13 2023-09-13 24900.46
2023-08-17 2023-09-12 26031.46
2023-08-16 2023-08-16 21150.69
2023-08-10 2023-08-15 26031.46
2023-07-18 2023-08-09 27162.46
2023-07-13 2023-07-17 22229.25
2023-06-16 2023-07-12 28293.46
2023-06-14 2023-06-15 24014.04
2023-05-16 2023-06-13 29424.46
2023-05-15 2023-05-15 25357.47
2023-05-02 2023-05-14 30555.46
2023-04-18 2023-04-28 30555.46
2023-04-17 2023-04-17 24110.90
2023-04-14 2023-04-16 30555.46
2023-03-14 2023-04-13 31686.46
2023-02-17 2023-03-13 32817.46
2023-02-14 2023-02-16 28294.75
2023-02-13 2023-02-13 32817.46
2023-02-06 2023-02-12 33948.46
2023-01-17 2023-02-03 33948.46
2023-01-16 2023-01-16 29480.06
2022-12-16 2023-01-15 35079.46
2022-12-15 2022-12-15 29936.32
2022-12-13 2022-12-14 35079.46
2022-11-24 2022-12-12 36210.46
2022-11-21 2022-11-23 41343.51
2022-11-17 2022-11-18 41343.51
2022-11-10 2022-11-16 36210.46
2022-10-18 2022-11-09 37341.46
2022-10-12 2022-10-17 32890.27
2022-10-10 2022-10-11 37341.54
2022-09-16 2022-10-09 38472.54
2022-09-15 2022-09-15 33805.67
2022-09-14 2022-09-14 33788.48
2022-09-13 2022-09-13 33797.24
2022-09-09 2022-09-12 38471.06
2022-09-08 2022-09-08 39602.06
2022-08-23 2022-09-07 39603.46
2022-08-16 2022-08-22 34063.81
2022-08-11 2022-08-15 39603.46
2022-07-18 2022-08-10 40734.46
2022-07-15 2022-07-17 36112.79
2022-06-16 2022-07-14 41865.46
2022-06-15 2022-06-15 37259.97
2022-05-17 2022-06-14 43001.76
2022-05-16 2022-05-16 38160.98
2022-04-25 2022-05-15 44132.98
2022-04-19 2022-04-24 44129.12
2022-04-15 2022-04-18 39321.59
2022-03-16 2022-04-14 45259.59
2022-03-15 2022-03-15 39278.43
2022-02-24 2022-03-14 46391.43
2022-02-17 2022-02-23 46391.43
2022-02-15 2022-02-16 40068.70
2022-01-26 2022-02-14 47522.70
2022-01-21 2022-01-25 47503.95
2022-01-18 2022-01-20 51003.95
2022-01-17 2022-01-17 37822.60
2021-12-16 2022-01-16 48653.60
2021-12-15 2021-12-15 39572.86
2021-11-16 2021-12-14 49784.60
2021-11-15 2021-11-15 41224.47
2021-10-18 2021-11-14 50611.23
2021-10-15 2021-10-17 43101.55
2021-10-07 2021-10-14 51742.23
2021-09-16 2021-10-06 52044.46

Essential Phosphates - VMI tax arrears

From To Overdue, €
2026-08-31 2026-08-31 8.68
2026-08-28 2026-08-30 16077.68
2026-07-02 2026-07-07 15.3
2026-06-28 2026-07-01 11350.0
2026-05-28 2026-05-28 18955.12
2026-04-30 2026-04-30 2.81
2026-03-29 2026-04-01 8658.74
2026-01-29 2026-01-30 27512.15
2026-01-01 2026-01-01 29015.08
2025-12-02 2025-12-02 33710.37
2025-11-28 2025-12-01 41268.0
2025-10-30 2025-10-30 12113.0
2025-09-28 2025-09-29 12166.15
2025-08-28 2025-08-28 11451.0
2025-07-28 2025-07-28 13193.0
2025-06-02 2025-06-14 0.24
2025-05-20 2025-05-24 0.15
2025-05-17 2025-05-19 123.03
2025-05-07 2025-05-16 123.0
2025-01-23 2025-01-23 0.14

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Essential Phosphates, UAB (code 304832983), a Private Limited Liability Company engaged in research and development in medical sciences, delivered a stronger financial performance in 2025. Revenue increased to €1.68M from €920.5K in 2024 and €1.44M in 2023, representing 82.1% year-on-year growth and 16.3% growth over two years. Net profit rose to €270.0K in 2025, compared with €162.0K in 2024, after a loss of €231.2K in 2023. The 2025 profit margin stood at 16.1%, indicating a stable level of profitability. Total assets reached €2.09M at year-end 2025, up from €1.65M in 2024 and €1.60M in 2023. Equity strengthened to €484.5K, while liabilities were €1.61M. The latest ratios show ROE of 55.7%, ROA of 12.9%, debt-to-equity of 3.32, and asset turnover of 0.80x. Revenue per employee was €88.2K in 2025, reflecting the company’s operating scale.